A Comparative Clinical study of Pushkarmulaadi churna with Anupana Bheda in the Management of Tamak Shavas with special reference to Bronchial Asthma
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- After completion of the trial period, the data obtained in both groups will be recorded, tabulated and statically analyzed using appropriate test
研究概览
简要总结
Tamakshavasa (bronchial asthma) is considered as main disease ofPranvahastrotas ( Respiratory tract). Bronchial Asthma is characterized by Paroxysm ofdyspnoea accompanied by wheezing resulting from narrowing of Bronchial airwaysby muscle spasm, mucosal swelling or viscid secretions. As stated by W.H.O.100-150 million of global population are suffering from Bronchial Asthma. Intoday stressfull modern urbanized living, incidence of Asthma is considerablyincreasing. The rapid industrialization, increasing pollution and excessivecrowding are some of the factors responsible for the increase of BronchialAsthma Disease. In modern it is mainly treated with steroids that actually weakens the lungs when used forlong term and come with many other side effects such as dryness, candida oryeast infection, lowered immunity, thinning of bronchiols rashes , Psoriasisand many more. So there is need of safe and effective medicine in Ayurveda forthe Treatment and Management of Tamak Shvasa( Bronchial asthma). Pushkarmulaadichurna is selected for trial. In one group Pushkarmulaadi Churna was given withluke warm water and in another groupPushkarmulaadi Churna was given with Honey.
研究设计
- 研究类型
- Interventional
- 分配方式
- Adaptive randomization, such as minimization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 16.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •a) Patients willing for trial.
- •b) Both male and female patients of agebetween 16 years to 80 years.
- •c) Patients having signs and symptoms of Tamak Shavas(Cough, Shortness of Breath,Expiratory wheeze etc.).
- •d) Night symptoms > twice per month.
- •e) Patients not having any state mentioned in exclusion criteria.
排除标准
- •Exclusion criteria:- a)Patients unwilling to participate in the trial.
- •b)Patients of age below 16 years and more than 80 years.
- •c)Alcoholics and drug abuses.
- •d)Pregnant and lactating women.
- •e)Severe cases of asthma with complication like suspected infections,large airway lesion,Status asthmatics etc.Cardiaccomplaints,other chronic disease T.B,AIDS,DiabetesMellitus,other systemic and endocrine complaints associated with any degree of asthma.
结局指标
主要结局
After completion of the trial period, the data obtained in both groups will be recorded, tabulated and statically analyzed using appropriate test
时间窗: After completion of the trial period, the data obtained in both groups will be recorded, tabulated and statically analyzed using appropriate test
次要结局
- data obtained in both groups will be recorded(data obtained in both groups will be recorded)